Skip to main content
. 2021 Jun 6;37(10):1619–1628. doi: 10.1016/j.cjca.2021.05.014

Figure 2.

Figure 2

Meta-regression results reporting clinical aspects of Kawasaki disease shock syndrome/Kawasaki disease(observed outcome) by incorporated study and by combined effect representing significant factors (P values for combined effect). IVIG, intravenous immunoglobulin; RE, random-effect.